FDA 483 - Puremedy Inc. - February 12, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Puremedy Inc., a topical homeopathic drug manufacturer in Westlake Village, CA, revealed significant deficiencies across its quality system, production, and laboratory controls. The firm lacked essential written procedures for quality control, process validation, and raw material identity testing. Furthermore, finished product testing relied on subjective sensory methods, and no stability assessments were documented for its homeopathic drug products.
ID · 2275324a-1216-4bc1-918a-9db30b6affd1